| 注册
首页|期刊导航|昆明医学院学报|云南汉族人群VKORC11173C/T基因多态性与华法林抗凝治疗维持剂量的相关性研究

云南汉族人群VKORC11173C/T基因多态性与华法林抗凝治疗维持剂量的相关性研究

刘建兴 陈智豫 李云萍 王通 吴春婷 李贺 许冰莹

昆明医学院学报2012,Vol.33Issue(6):13-17,5.
昆明医学院学报2012,Vol.33Issue(6):13-17,5.

云南汉族人群VKORC11173C/T基因多态性与华法林抗凝治疗维持剂量的相关性研究

Relationship between Genetic Polymorphism of VKORC1 1173C/T and Warfarin Dose Requirments in Yunnan Han Population

刘建兴 1陈智豫 2李云萍 3王通 1吴春婷 1李贺 1许冰莹1

作者信息

  • 1. 昆明医科大学法医学院,云南,昆明,650500
  • 2. 昆明医科大学附属延安医院,云南,昆明,650051
  • 3. 四川省公安厅刑侦局,四川,成都,610041
  • 折叠

摘要

Abstract

Objective To investigate the polymorphism distribution and characteristics of VKORC1 1173C/T, as well as the relationship between the polymorphism and warfarin dose requirments in Han population in Yunnan. Methods Blood samples were collected from 300 patients with stable warfarin dose requirements, PCR-RFLP techniques were used to detect genes and genotypes of VKORC1 1173C/T, and international normalized ratio (INR) of the prothrombin time within the target range (1.5-3.0) , polymorphisms for VKORC 1 1173C/T were also analyzed. Results We obtained two alleles of C and T, with the frequencies of 10% and 90% , respectively. The genotypes showed that 80% patients were homozygous TT; and 20% were heterozygous CT. No differences were found between age and gendre. Patients with CT genotypes required higher warfarin dose (3.62 ± 1.35 mg/day) than those with TT (3.12 ± 1.17 mg/day; CT:TT p = 0.007). Conclusion VKORC1 1173C/T gene distribution in Yunnan Han is different from those in other populations, and some suggestions are given for individual use of warfarin in Yunan Han population.

关键词

云南地区/汉族/华法林/VKORC1/基因多态性

Key words

Yunan/ Han/ Warfarin/ VKORC1/ Genetic polymorphism

分类

药学

引用本文复制引用

刘建兴,陈智豫,李云萍,王通,吴春婷,李贺,许冰莹..云南汉族人群VKORC11173C/T基因多态性与华法林抗凝治疗维持剂量的相关性研究[J].昆明医学院学报,2012,33(6):13-17,5.

基金项目

国家自然科学基金资助项目(30860339),云南省社会发展科技计划项目(2009ZC155M) (30860339)

昆明医学院学报

OACSTPCD

1003-4706

访问量0
|
下载量0
段落导航相关论文